PATRICK R. O'NEIL
CIK 1564926 · EVP CLO & General Counsel · last filed 2026-03-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.31M
Companies
2
Total Filings
130
Lifetime Open-Market Net
-$35.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP CLO & General Counsel | 62,211 | $53.28 | $3.31M | -$30.73M | 83 | 2026-03-11 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | SVP, Legal & General Counsel | 7,259 | — | — | -$5.16M | 29 | 2015-12-02 |
Recent Filings · Page 11 of 13
130 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-04 | IONS | Mixed | +43 | -$51.3K | EDGAR |
| 2015-12-02 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$54.2K | EDGAR |
| 2015-11-04 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$44.7K | EDGAR |
| 2015-07-02 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Other (J) | +85 | $4.1K | EDGAR |
| 2015-03-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$1.59M | EDGAR |
| 2015-03-09 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$359.8K | EDGAR |
| 2015-01-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +2,092 | -$87.7K | EDGAR |
| 2015-01-05 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +329 | -$68.1K | EDGAR |
| 2014-12-03 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | −1,000 | -$73.2K | EDGAR |
| 2014-11-05 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$58.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.